FIBROGEN INC Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FIBROGEN INC for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 9,042 | 32,551 | 454,061 | |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 9,042 | 32,551 | 463,103 | |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.13 | 918 | 46,937 | 118,662 | 119.6 K to 118.7 K (-0.77 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.63 | 900 | 46,467 | 2,940,493 | 2.9 M to 2.9 M (-0.03 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.17 | 18,000 | 921,060 | 2,941,393 | 3 M to 2.9 M (-0.61 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 9,042 | 32,551 | 2,959,393 | 3 M to 3 M (+0.31 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 50.71 | 918 | 46,552 | 119,580 | 120.5 K to 119.6 K (-0.76 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 51.02 | 3,968 | 202,447 | 2,950,351 | 3 M to 3 M (-0.13 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 50.64 | 14,932 | 756,156 | 2,954,319 | 3 M to 3 M (-0.50 %) |
| Mar 22 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 9,042 | 32,551 | 2,969,251 | 3 M to 3 M (+0.31 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | A | 53.75 | 55,000 | 2,956,250 | 55,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Grant | A | 0.00 | 32,000 | 0 | 160,333 | 128.3 K to 160.3 K (+24.94 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 53.20 | 9,891 | 526,201 | 128,333 | 138.2 K to 128.3 K (-7.16 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 9,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.78 | 300 | 15,834 | 29,000 | 29.3 K to 29 K (-1.02 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.15 | 700 | 36,505 | 29,300 | 30 K to 29.3 K (-2.33 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 53.75 | 110,000 | 5,912,500 | 110,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 70,000 | 0 | 2,960,209 | 2.9 M to 3 M (+2.42 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 4,000 | |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 53.05 | 1,100 | 58,355 | 20,000 | 21.1 K to 20 K (-5.21 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 52.21 | 2,900 | 151,409 | 21,100 | 24 K to 21.1 K (-12.08 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 24,000 | 20 K to 24 K (+20.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.34 | 12,000 | 220,080 | 0 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.00 | 12,000 | 216,000 | 0 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.53 | 9,844 | 526,949 | 48,000 | 57.8 K to 48 K (-17.02 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.26 | 14,156 | 753,949 | 57,844 | 72 K to 57.8 K (-19.66 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.34 | 12,000 | 220,080 | 72,000 | 60 K to 72 K (+20.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.00 | 12,000 | 216,000 | 60,000 | 48 K to 60 K (+25.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 19.39 | 14,000 | 271,460 | 46,000 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 29.66 | 22,094 | 655,308 | 20,042 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | A | 53.75 | 38,000 | 2,042,500 | 38,000 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 53.08 | 13,804 | 732,716 | 196,334 | 210.1 K to 196.3 K (-6.57 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 52.23 | 22,290 | 1,164,207 | 210,138 | 232.4 K to 210.1 K (-9.59 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 29.66 | 22,094 | 655,308 | 232,428 | 210.3 K to 232.4 K (+10.50 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 19.39 | 14,000 | 271,460 | 210,334 | 196.3 K to 210.3 K (+7.13 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 28,000 | 0 | 196,334 | 168.3 K to 196.3 K (+16.63 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.61 | 5,932 | 323,947 | 168,334 | 174.3 K to 168.3 K (-3.40 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.19 | 2,618 | 144,487 | 379,200 | 381.8 K to 379.2 K (-0.69 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.90 | 4,382 | 240,572 | 381,818 | 386.2 K to 381.8 K (-1.13 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 53.07 | 5,402 | 286,684 | 386,200 | 391.6 K to 386.2 K (-1.38 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.98 | 19,693 | 1,082,721 | 391,602 | 411.3 K to 391.6 K (-4.79 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 6,000 | 21,600 | 0 | |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 12,000 | 43,200 | 0 | |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 55.00 | 18,000 | 990,000 | 135,064 | 153.1 K to 135.1 K (-11.76 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | M | 3.60 | 18,000 | 64,800 | 153,064 | 135.1 K to 153.1 K (+13.33 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Gift | G | 0.00 | 500 | 0 | 135,064 | 135.6 K to 135.1 K (-0.37 %) |
| Mar 09 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.75 | 22,905 | 1,276,954 | 411,295 | 434.2 K to 411.3 K (-5.28 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 53.55 | 5,065 | 271,231 | 138,224 | 143.3 K to 138.2 K (-3.53 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 3,314 | 11,930 | 472,145 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 7,005 | 16,462 | 0 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 10,265 | 24,123 | 7,005 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.59 | 618 | 33,119 | 120,498 | 121.1 K to 120.5 K (-0.51 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.55 | 300 | 15,765 | 121,116 | 121.4 K to 121.1 K (-0.25 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.09 | 700 | 37,863 | 2,890,209 | 2.9 M to 2.9 M (-0.02 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.44 | 11,800 | 630,592 | 2,890,909 | 2.9 M to 2.9 M (-0.41 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.74 | 6,400 | 337,536 | 2,902,709 | 2.9 M to 2.9 M (-0.22 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 3,314 | 11,930 | 2,909,109 | 2.9 M to 2.9 M (+0.11 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 7,005 | 16,462 | 2,905,795 | 2.9 M to 2.9 M (+0.24 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.91 | 218 | 11,752 | 121,416 | 121.6 K to 121.4 K (-0.18 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.82 | 700 | 36,974 | 121,634 | 122.3 K to 121.6 K (-0.57 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.14 | 2,298 | 124,414 | 2,898,790 | 2.9 M to 2.9 M (-0.08 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.26 | 7,800 | 415,428 | 2,901,088 | 2.9 M to 2.9 M (-0.27 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.58 | 8,802 | 462,809 | 2,908,888 | 2.9 M to 2.9 M (-0.30 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 10,265 | 24,123 | 2,917,690 | 2.9 M to 2.9 M (+0.35 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 53.55 | 16,199 | 867,456 | 2,907,425 | 2.9 M to 2.9 M (-0.55 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.47 | 79 | 4,303 | 174,266 | 174.3 K to 174.3 K (-0.05 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 53.45 | 909 | 48,586 | 174,345 | 175.3 K to 174.3 K (-0.52 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 52.68 | 906 | 47,728 | 175,254 | 176.2 K to 175.3 K (-0.51 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 53.55 | 5,832 | 312,304 | 176,160 | 182 K to 176.2 K (-3.20 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 54.95 | 1,297 | 71,270 | 143,289 | 144.6 K to 143.3 K (-0.90 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 54.95 | 4,455 | 244,802 | 2,923,624 | 2.9 M to 2.9 M (-0.15 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 54.95 | 1,860 | 102,207 | 181,992 | 183.9 K to 182 K (-1.01 %) |